• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体皮肤利什曼病治疗失败、复发和慢性患者的主要危险因素和组织病理学特征:治疗结果的前瞻性病例对照研究及其医学重要性。

Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.

机构信息

Leishmaniasis Research Center, Kerman Univeprsity of Medical Sciences, Kerman, Iran.

Department of Pathology, Afzalipour Hospital, Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

PLoS Negl Trop Dis. 2021 Jan 28;15(1):e0009089. doi: 10.1371/journal.pntd.0009089. eCollection 2021 Jan.

DOI:10.1371/journal.pntd.0009089
PMID:33507940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7872302/
Abstract

Over the last years, there has been a remarkable increase in the number of unresponsive patients with anthroponotic cutaneous leishmaniasis (ACL) reported worldwide. The primary objective of this study was to explore the role of demographic, clinical and environmental risk related-factors in the development of treatment failure, relapse and chronic cases compared to responsive patients with ACL. Moreover, molecular, histopathological and immunohistochemical (IHC) findings between these forms were explored. This work was undertaken as a prospective and case-control study in southeastern Iran. Culture media and nested PCR were used to identify the causative agent. Univariate multinomial and multiple multinomial logistic regression models and the backward elimination stepwise method were applied to analyze the data. A P<0.05 was defined as significant. Also, for different groups, skin punch biopsies were used to study the histopathological and immunohistochemical (IHC) profile. All samples showed that L. tropica was the only etiological agent in all unresponsive and responsive patients with ACL. Data analysis represented that 8 major risk factors including nationality, age groups, occupation, marital status, history of chronic diseases, duration of the lesion, the lesion on face and presence of domestic animals in the house were significantly associated with the induction of unresponsive forms. The histopathological and immunohistochemical findings were different from one form to another. The present findings clearly demonstrated a positive relation between ACL and distinct demographic, clinical and environmental risk determinants. Knowledge of the main risk factors for ACL infection is crucial in improving clinical and public health strategies and monitor such perplexing factors.

摘要

在过去的几年中,全球范围内报告的无反应性人类皮肤利什曼病(ACL)患者数量显著增加。本研究的主要目的是探讨与人口统计学、临床和环境风险相关因素在治疗失败、复发和慢性病例中的作用,与有反应性 ACL 患者相比。此外,还探讨了这些形式之间的分子、组织病理学和免疫组织化学(IHC)发现。这项工作是在伊朗东南部进行的前瞻性病例对照研究。使用培养介质和巢式 PCR 来鉴定病原体。应用单变量多项和多项多项逻辑回归模型以及向后消除逐步法来分析数据。P<0.05 被定义为显著。此外,对于不同的组,皮肤打孔活检用于研究组织病理学和免疫组织化学(IHC)图谱。所有样本均表明,L. tropica 是所有无反应性和有反应性 ACL 患者的唯一病因。数据分析表明,8 个主要危险因素,包括国籍、年龄组、职业、婚姻状况、慢性病史、病变持续时间、面部病变和家中是否有家畜,与无反应性的发生显著相关。组织病理学和免疫组织化学发现形式之间存在差异。目前的研究结果清楚地表明 ACL 与不同的人口统计学、临床和环境风险决定因素之间存在正相关。了解 ACL 感染的主要危险因素对于改善临床和公共卫生策略以及监测这些复杂因素至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/c49af3864ebf/pntd.0009089.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/dce9beb60f5d/pntd.0009089.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/ecca936ac9db/pntd.0009089.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/487b34878bc6/pntd.0009089.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/3a153a3f57f6/pntd.0009089.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/15d621e0edd0/pntd.0009089.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/c49af3864ebf/pntd.0009089.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/dce9beb60f5d/pntd.0009089.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/ecca936ac9db/pntd.0009089.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/487b34878bc6/pntd.0009089.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/3a153a3f57f6/pntd.0009089.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/15d621e0edd0/pntd.0009089.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea4/7872302/c49af3864ebf/pntd.0009089.g006.jpg

相似文献

1
Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.人体皮肤利什曼病治疗失败、复发和慢性患者的主要危险因素和组织病理学特征:治疗结果的前瞻性病例对照研究及其医学重要性。
PLoS Negl Trop Dis. 2021 Jan 28;15(1):e0009089. doi: 10.1371/journal.pntd.0009089. eCollection 2021 Jan.
2
Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.伊朗东南部一个主要疫源地中无反应型和有反应型患者的人源性皮肤利什曼病危险因素。
PLoS One. 2018 Feb 7;13(2):e0192236. doi: 10.1371/journal.pone.0192236. eCollection 2018.
3
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.伴发病决定因素与葡萄糖酸锑钠治疗的人源皮肤利什曼病:伊朗的队列研究。
PLoS Negl Trop Dis. 2019 Jun 12;13(6):e0007423. doi: 10.1371/journal.pntd.0007423. eCollection 2019 Jun.
4
Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.宿主对米氮平治疗的人源化皮肤利什曼病无反应和有反应患者的免疫反应:Th1 和 Th2 途径的病例对照研究。
Int Immunopharmacol. 2019 Apr;69:321-327. doi: 10.1016/j.intimp.2019.02.008. Epub 2019 Feb 14.
5
Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.热带利什曼原虫引起的人源化皮肤利什曼病中,葡萄糖酸锑钠治疗无应答和有应答患者外周血单核细胞 TLRs 2、4、9、iNOS 和 TNF-α 的差异表达及精氨酸酶活性。
Microb Pathog. 2019 Jan;126:368-378. doi: 10.1016/j.micpath.2018.11.004. Epub 2018 Nov 3.
6
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.无反应性 meglumine antimoniate 在人间皮肤利什曼病野外分离株:通过基因表达谱分析耐药生物标志物。
Trop Med Int Health. 2018 Jun;23(6):622-633. doi: 10.1111/tmi.13062. Epub 2018 May 21.
7
A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor.伊朗东南部一种长期存在的人间皮肤利什曼病的新发流行:人口流动和城郊住区是主要危险因素。
Parasit Vectors. 2021 Feb 24;14(1):122. doi: 10.1186/s13071-021-04619-3.
8
Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: Clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis.伊朗东南部城市皮肤利什曼病向农村地区的蔓延:使用 7SL 高分辨率熔解 PCR 分析探索临床、流行病学和系统发育特征。
Transbound Emerg Dis. 2019 Jul;66(4):1602-1610. doi: 10.1111/tbed.13186. Epub 2019 Apr 15.
9
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.一单组临床试验:针对人源化皮肤利什曼病的终末期患者:在野外和实验室模型中联合使用左旋咪唑和葡萄糖酸锑钠。
Microb Pathog. 2019 Mar;128:162-170. doi: 10.1016/j.micpath.2018.12.040. Epub 2018 Dec 21.
10
Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran.治疗依从性差是影响皮肤利什曼病治疗效果的主要障碍:伊朗的一项病例对照现场评估。
Int J Parasitol Drugs Drug Resist. 2023 Apr;21:21-27. doi: 10.1016/j.ijpddr.2022.11.006. Epub 2022 Dec 5.

引用本文的文献

1
An inclusive assessment of apoptosis mechanisms in species: A narrative literature review.物种凋亡机制的综合评估:一篇叙述性文献综述
Curr Res Parasitol Vector Borne Dis. 2025 Apr 17;7:100260. doi: 10.1016/j.crpvbd.2025.100260. eCollection 2025.
2
Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis.患者与医疗保健系统在皮肤利什曼病控制中的相互作用
Transbound Emerg Dis. 2023 Aug 26;2023:7814940. doi: 10.1155/2023/7814940. eCollection 2023.
3
Unlocking Responsive and Unresponsive Signatures: A Transfer Learning Approach for Automated Classification in Cutaneous Leishmaniasis Lesions.

本文引用的文献

1
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.伴发病决定因素与葡萄糖酸锑钠治疗的人源皮肤利什曼病:伊朗的队列研究。
PLoS Negl Trop Dis. 2019 Jun 12;13(6):e0007423. doi: 10.1371/journal.pntd.0007423. eCollection 2019 Jun.
2
Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates.皮肤利什曼病与共病严重抑郁症:负担评估的系统评价。
PLoS Negl Trop Dis. 2019 Feb 25;13(2):e0007092. doi: 10.1371/journal.pntd.0007092. eCollection 2019 Feb.
3
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
解锁反应性和无反应性特征:一种用于皮肤利什曼病病变自动分类的迁移学习方法。
Transbound Emerg Dis. 2025 Jan 21;2025:5018632. doi: 10.1155/tbed/5018632. eCollection 2025.
4
The developing role of NRF2 and HMOX1 in treatment response of cutaneous leishmaniasis.NRF2和HMOX1在皮肤利什曼病治疗反应中的发展作用。
Sci Rep. 2025 Apr 29;15(1):14988. doi: 10.1038/s41598-025-99456-0.
5
Preparation, Characterization, and Leishmanicidal Assessment of Silver- and Dapsone-Loaded Niosomes Co-administration: and Study.载银和氨苯砜的非离子表面活性剂囊泡联合给药的制备、表征及抗利什曼原虫评估:一项研究
Adv Pharm Bull. 2024 Dec 30;14(4):892-907. doi: 10.34172/apb.42740. Epub 2024 Dec 5.
6
Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis.在控制利什曼病方面实现可持续发展目标的全球困境与需求评估
J Epidemiol Glob Health. 2024 Mar;14(1):22-34. doi: 10.1007/s44197-024-00190-z. Epub 2024 Mar 11.
7
Geographical and climatic risk factors of cutaneous leishmaniasis in the hyper-endemic focus of Bam County in southeast Iran.伊朗东南部 Bam 县高度流行地区皮肤利什曼病的地理和气候风险因素。
Front Public Health. 2023 Nov 9;11:1236552. doi: 10.3389/fpubh.2023.1236552. eCollection 2023.
8
Systematic Review of Treatment Failure and Clinical Relapses in Leishmaniasis from a Multifactorial Perspective: Clinical Aspects, Factors Associated with the Parasite and Host.从多因素角度对利什曼病治疗失败和临床复发的系统评价:临床方面、与寄生虫和宿主相关的因素
Trop Med Infect Dis. 2023 Aug 29;8(9):430. doi: 10.3390/tropicalmed8090430.
9
Histological findings associated with treatment response in cutaneous leishmaniasis: a clinicopathological correlation study.与皮肤利什曼病治疗反应相关的组织学发现:一项临床病理相关性研究。
Int J Dermatol. 2023 Oct;62(10):1237-1247. doi: 10.1111/ijd.16826.
10
Healing effects of autologous platelet gel and growth factors on cutaneous leishmaniasis wounds in addition to antimony; a self-controlled clinical trial with randomized lesion assignment.自身血小板凝胶和生长因子对锑治疗皮肤利什曼病创面的愈合作用:随机分组病变自身对照临床试验。
BMC Res Notes. 2023 Sep 9;16(1):200. doi: 10.1186/s13104-023-06470-4.
一单组临床试验:针对人源化皮肤利什曼病的终末期患者:在野外和实验室模型中联合使用左旋咪唑和葡萄糖酸锑钠。
Microb Pathog. 2019 Mar;128:162-170. doi: 10.1016/j.micpath.2018.12.040. Epub 2018 Dec 21.
4
Leishmaniasis recidivans by Leishmania tropica in Central Rift Valley Region in Kenya.肯尼亚中央裂谷地区由热带利什曼原虫引起的复发性利什曼病。
Int J Infect Dis. 2018 Sep;74:109-116. doi: 10.1016/j.ijid.2018.07.008. Epub 2018 Jul 11.
5
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.无反应性 meglumine antimoniate 在人间皮肤利什曼病野外分离株:通过基因表达谱分析耐药生物标志物。
Trop Med Int Health. 2018 Jun;23(6):622-633. doi: 10.1111/tmi.13062. Epub 2018 May 21.
6
Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.伊朗东南部一个主要疫源地中无反应型和有反应型患者的人源性皮肤利什曼病危险因素。
PLoS One. 2018 Feb 7;13(2):e0192236. doi: 10.1371/journal.pone.0192236. eCollection 2018.
7
Leishmania tropica isolates from non-healed and healed patients in Iran: A molecular typing and phylogenetic analysis.伊朗未愈和已愈患者中的热带利什曼原虫分离株:分子分型和系统发生分析。
Microb Pathog. 2018 Mar;116:124-129. doi: 10.1016/j.micpath.2018.01.021. Epub 2018 Jan 17.
8
Clinical Features of Anthroponotic Cutaneous Leishmaniasis in a Major Focus, Southeastern Iran, 1994-2014.1994 - 2014年伊朗东南部主要疫区人源性皮肤利什曼病的临床特征
Iran J Parasitol. 2017 Oct-Dec;12(4):544-553.
9
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.利什曼病中的耐药性与治疗失败:21世纪的挑战。
PLoS Negl Trop Dis. 2017 Dec 14;11(12):e0006052. doi: 10.1371/journal.pntd.0006052. eCollection 2017 Dec.
10
A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates.皮肤利什曼病的新视角——对全球患病率及疾病负担估计的影响
PLoS Negl Trop Dis. 2017 Aug 10;11(8):e0005739. doi: 10.1371/journal.pntd.0005739. eCollection 2017 Aug.